Asymmetric bioreductions: application to the synthesis of pharmaceuticals

Journal of Molecular Catalysis - B Enzymatic

Volumn 11, Issue 4-6, 2001, Pages 503-512

  Chartrain, Michel ^a   Greasham, Randolph ^a   Moore, Jeffrey ^a   Reider, Paul ^a   Robinson, David ^a   Buckland, Barry ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Assymetric bioreductions; Fermentation; Ketones; Process development

Indexed keywords

ALCOHOL DERIVATIVE; KETONE;

BIOCATALYST; BIOREACTOR; BIOTRANSFORMATION; CANDIDA; CHIRALITY; CONFERENCE PAPER; CULTURE MEDIUM; DRUG SYNTHESIS; ENANTIOMER; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METHODOLOGY; MICROORGANISM; REACTION ANALYSIS; REDUCTION; SCREENING; TECHNIQUE;

CANDIDA SORBOPHILA;

EID: 0035931613     PISSN: 13811177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1381-1177(00)00170-3     Document Type: Conference Paper

References (30)

1. Nonchiral, homochiral and composite chiral drugs
2. Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States
3. Counting on chiral drugs
4. Enzymes in organic synthesis
5. Baker's yeast mediated transformations in organic chemistry
6. Asymmetric reduction of ketones with microbes
7. Baker's yeast as a reagent in organic synthesis
8. Reductive biotransformations of organic compounds by cells or enzymes of yeast
9. Large scale production of chiral alcohols with baker's yeast
10. Biotransformations using clostridia: Stereospecific reductions of a b-ketoester
11. Implementation of a rapid microbial screening procedure for biotransformation activities
12. Asymmetric bioreduction of a β-tetralone to its corresponding (S) alcohol by the yeast Trichosporon capitatum MY 1890
13. Purification and characterization of two oxydoreductases involved in the enantioselective reduction of 3-oxo, 4-oxo, and 5-oxo esters in bakers' yeast
14. Production of (+)-(S)-ethyl-3-hydroxybutyrate and of (-)-(R)-ethyl-3-hydroxybutyrate by microbial reduction of ethyl acetoacetate
15. Asymmetric bioreduction of ketosulfone to the corresponding trans-hydroxysulfone by the yeast Rhodotorulla rubra MY 2169
16. Asymmetric bioreduction of (2-(4-nitro-phenyl)-N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide) to its corresponding (R) alcohol [(R)-N-(2-hydroxy-2-pyridin-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide], employing Candida sorbophila MY 1833
17. Asymmetric bioreduction of a beta-ketoester to (R)-beta-hydroxyester by the fungus Mortierella alpina MF 5534
18. Asymmetric bioreduction of a ketoester to its corresponding (S)-hydroxyester by Microbacterium sp. MB 5614
19. Directed evolution of biocatalysts
20. Biocatalysis for pharmaceuticals. Status and prospects for a key technology
21. Asymmetric bioreduction of benzyl acetoacetate to its corresponding alcohol, benzyl (S)-(+)-3-hydroxybutyrate by the yeast Candida schatavii MY 1831
22. Asymmetric bioreduction of cyclohexylphenyl ketone to (+)-cyclohexylphenyl alcohol by the yeast Candida magnolia MY 1785
23. Asymmetric bioreduction of a bisaryl ketone to uts corresponding alcohol by the yeast Rhodotorula pilimanae
24. Asymmetic direduction of 1,2-Indandione to cis (1S,2R) indandiol by Thrychospora cutaneum MY 1506
25. Asymmetric bioreduction of an allylic alcohol to its corresponding (R)-alcohol
26. Asymmetric biosynthesis of key intermediates in the synthesis of an endothelin receptor antagonist